KPMG report: Telemedicine and tax (COVID-19)

KPMG report: Telemedicine and tax (COVID-19)

The coronavirus (COVID-19) pandemic served as an unexpected catalyst driving newfound popularity of virtual healthcare. Recent changes to regulatory and reimbursement rules for telemedicine further boosted its appeal as a safe healthcare option.


Despite being around for decades, telemedicine’s accelerated acceptance thrust the need for greater clarity on tax guidance into the spotlight. Existing guidance does not delve into the digital world, leaving much up to interpretation, such as:

  • What defines the doctor and patient relationship in the virtual world?
  • What federal income tax issues apply to both taxable and tax-exempt healthcare providers who employ telemedicine?
  • When the use of telemedicine crosses state lines, what are the state and local tax consequences?
  • What tax issues arise with health plan accounts, R&D tax accounts, and international tax implications?

Read a 2020 report [PDF 590 KB] from KPMG LLP that examines various tax considerations relating to telemedicine and explores several hypothetical scenarios providing possible interpretations of tax outcomes.

© 2022 KPMG LLP, a Delaware limited liability partnership and a member firm of the KPMG global organization of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.

For more detail about the structure of the KPMG global organization please visit

The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 4366, 1801 K Street NW, Washington, DC 20006.

Connect with us